Skip to main content

Advertisement

Log in

Interleukin-10 Polymorphisms, Cancer Susceptibility and Prognosis

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Interleukin-10 (IL-10) is a multifunctional cytokine with both immunosuppressive and anti-angiogenic functions and may have both tumour-promoting and -inhibiting properties. A large number of polymorphisms (primarily single nucleotide polymorphisms (SNPs)) have been identified in the IL-10 gene promoter. Convincing evidence that certain of these polymorphisms are associated with differential expression of IL-10 in vitro and in some cases in vivo has been obtained and a number of studies have investigated associations between IL-10 polymorphisms and cancer susceptibility/prognosis. The results from 22 studies in 13 different malignancies are reviewed. In 17 of these studies, positive associations between IL-10 genotype or haplotype and disease susceptibility and/or progression were reported. In some of these cancers genotypes associated with low IL-10 expression were a risk factor for disease or disease progression, while in others genotypes associated with high IL-10 expression were a risk factor. Published findings in breast cancer are as yet conflicting. Most, but not all of the studies reviewed are based on small sample sizes and a limited number of IL-10 polymorphisms. However, the preliminary data obtained thus far indicate that larger studies are required in a number of cancers, in order to confirm initial results, extend studies to include more detailed genotype/haplotype analysis and combine genotype and gene expression studies in the same subjects. Such studies will contribute significantly to our understanding of the biological role of IL-10 in cancer development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

HLA:

human leukocyte antigen

IL:

interleukin

LTA:

lymphotoxin alpha

NHL:

Non-Hodgkin’s lymphoma

SNP:

single nucleotide polymorphism

TGFB:

transforming growth factor beta

TNFA:

tumour necrosis factor

References

  1. Y Miki J Swensen D Shattuck-Eidens et al. (1994) ArticleTitleA strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66–71 Occurrence Handle7545954 Occurrence Handle1:CAS:528:DyaK2MXhtF2ns70%3D

    PubMed  CAS  Google Scholar 

  2. R Wooster G Bignell J Lancaster et al. (1995) ArticleTitleIdentification of the breast cancer susceptibility gene BRCA2 Nature 378 789–92 Occurrence Handle8524414 Occurrence Handle1:CAS:528:DyaK28XltFWi Occurrence Handle10.1038/378789a0

    Article  PubMed  CAS  Google Scholar 

  3. MA Blackwood BL. Weber (1998) ArticleTitleBRCA1 and BRCA2: from molecular genetics to clinical medicine J Clin Oncol 16 1969–77 Occurrence Handle9586917 Occurrence Handle1:CAS:528:DyaK1cXjtFOqt7o%3D

    PubMed  CAS  Google Scholar 

  4. JR Smith D Freije JD Carpten et al. (1996) ArticleTitleMajor susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search Science 274 1371–4 Occurrence Handle8910276 Occurrence Handle1:CAS:528:DyaK28XntFKlsr0%3D Occurrence Handle10.1126/science.274.5291.1371

    Article  PubMed  CAS  Google Scholar 

  5. J Xu D Meyers D Freije S Isaccs et al. (1998) ArticleTitleEvidence for a prostate cancer susceptibility locus on the X chromosome Nat Genet 20 175–9 Occurrence Handle9771711 Occurrence Handle1:CAS:528:DyaK1cXms1aqtrw%3D Occurrence Handle10.1038/2477

    Article  PubMed  CAS  Google Scholar 

  6. D Ford DF Easton DT Bishop SA Narod DE Goldger (1994) ArticleTitleRisk of cancer in BRCA1 mutation carriers Lancet 343 692–5 Occurrence Handle7907678 Occurrence Handle1:STN:280:ByuC1c%2FmtFM%3D Occurrence Handle10.1016/S0140-6736(94)91578-4

    Article  PubMed  CAS  Google Scholar 

  7. M Gibbs JL Stanford RA McIndoe et al. (1999) ArticleTitleEvidence for a rare prostate cancer-susceptibility locus at chromosome 1p36 Am J Hum Genet 64 776–87 Occurrence Handle10053012 Occurrence Handle1:CAS:528:DyaK1MXitFCht7k%3D Occurrence Handle10.1086/302287

    Article  PubMed  CAS  Google Scholar 

  8. P Berthon A Valeri A Cohen-Akenine et al. (1998) ArticleTitlePredisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2–43 Am J Hum Genet 62 1416–24 Occurrence Handle9585607 Occurrence Handle1:CAS:528:DyaK1cXlslCiu7o%3D Occurrence Handle10.1086/301879

    Article  PubMed  CAS  Google Scholar 

  9. SV Tavtigian J Simard DH Teng et al. (2001) ArticleTitleA strong candidate prostate cancer susceptibility gene at chromosome 17p Nat Genet 27 172–80 Occurrence Handle11175785 Occurrence Handle1:CAS:528:DC%2BD3MXhtFGktLc%3D Occurrence Handle10.1038/84808

    Article  PubMed  CAS  Google Scholar 

  10. K Nathanson BL Weber (2001) ArticleTitle“Other” breast cancer susceptibility genes: searching for more holy grail Hum Mol Genet 10 715–20 Occurrence Handle11257104 Occurrence Handle1:CAS:528:DC%2BD3MXjt1ajsbw%3D Occurrence Handle10.1093/hmg/10.7.715

    Article  PubMed  CAS  Google Scholar 

  11. PD Pharoah A Antoniou M Bobrow RL Zimmern DF Easton BA Ponder (2002) ArticleTitlePolygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 33–6 Occurrence Handle11984562 Occurrence Handle1:CAS:528:DC%2BD38Xjt1Kgu7g%3D Occurrence Handle10.1038/ng853

    Article  PubMed  CAS  Google Scholar 

  12. R Wooster G Bignell J Lancaster et al. (1995) ArticleTitleIdentification of the breast cancer susceptibility gene BRCA2 Nature 378 789–92 Occurrence Handle8524414 Occurrence Handle1:CAS:528:DyaK28XltFWi Occurrence Handle10.1038/378789a0

    Article  PubMed  CAS  Google Scholar 

  13. J Charrier CM Maugard B LeMevel YJ Bignon (1999) ArticleTitleAllelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility Br J Cancer 79 346–53 Occurrence Handle9888479 Occurrence Handle1:CAS:528:DyaK1MXmvFeguw%3D%3D

    PubMed  CAS  Google Scholar 

  14. M Bergman-Jungestrom M Gentile A Lundin (1999) ArticleTitleThe South East Breast Cancer Group, Wingren S. Association between CYP17 gene polymorphism and risk of breast cancer in young women Int J Cancer 84 350–3 Occurrence Handle10404084 Occurrence Handle1:CAS:528:DyaK1MXkvFansrc%3D Occurrence Handle10.1002/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3.0.CO;2-L

    Article  PubMed  CAS  Google Scholar 

  15. AM Dunning CS Healey PDP Pharaoh MD Teare BAJ Ponder DF Easton (1999) ArticleTitleA systematic review of genetic polymorphisms and breast cancer risk Cancer Epidemiol Biomark Prev 8 843–54 Occurrence Handle1:CAS:528:DyaK1MXns1CrtLw%3D

    CAS  Google Scholar 

  16. AC Bateman WM Howell (1999) ArticleTitleHuman leukocyte antigens and cancer: is it in our genes? J Pathol 188 231–6 Occurrence Handle10419588 Occurrence Handle1:CAS:528:DyaK1MXltVKrtbc%3D Occurrence Handle10.1002/(SICI)1096-9896(199907)188:3<231::AID-PATH325>3.0.CO;2-A

    Article  PubMed  CAS  Google Scholar 

  17. J Bidwell L Keen G Gallagher et al. (1999) ArticleTitleCytokine gene polymorphism in human disease: on-line databases Genes Immun 1 3–19 Occurrence Handle11197303 Occurrence Handle1:CAS:528:DC%2BD3cXktlyiurk%3D Occurrence Handle10.1038/sj.gene.6363645

    Article  PubMed  CAS  Google Scholar 

  18. Haukim N, Bidwell JL, Smith AJP, et al. Cytokine gene polymorphism in human disease: on-line databases, Supplement 2. Genes Immun 2002; 313–30

  19. J Demeter F Porzsolt S Ramisch et al. (1997) ArticleTitlePolymorphism of the␣tumour necrosis factor-alpha and Lymphotoxin-alpha genes in chronic lymphocytic leukaemia Br J Haematol 97 107–12 Occurrence Handle9136948 Occurrence Handle1:STN:280:ByiB1c3mtl0%3D Occurrence Handle10.1046/j.1365-2141.1997.9912636.x

    Article  PubMed  CAS  Google Scholar 

  20. K Warzocha P Ribeiro J Bienvenu et al. (1998) ArticleTitleGenetic polymorphisms in the tumour necrosis factor locus influence non-Hodgkin;s lymphoma outcome Blood 91 3574–81 Occurrence Handle9572991 Occurrence Handle1:CAS:528:DyaK1cXjtFersro%3D

    PubMed  CAS  Google Scholar 

  21. S Mestiri N Bouaouina SB Ahmed et al. (2001) ArticleTitleGenetic variation in the tumour necrosis factor-α promoter region and in the stress protein hsp70–2 Cancer 91 672–8 Occurrence Handle11241233 Occurrence Handle1:CAS:528:DC%2BD3MXhsFCrt7c%3D Occurrence Handle10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J

    Article  PubMed  CAS  Google Scholar 

  22. C Wihlborg J Sjoberg M Intaglietta et al. (1999) ArticleTitleTumour necrosis factor-α cytokine promoter polymorphism in Hodgkin’s disease and chronic lymphocytic leukaemia Br J Haematol 104 346–9 Occurrence Handle10050718 Occurrence Handle1:CAS:528:DyaK1MXhsV2gtr4%3D Occurrence Handle10.1046/j.1365-2141.1999.01176.x

    Article  PubMed  CAS  Google Scholar 

  23. KS Park JW Mok HE Ko et al. (2002) ArticleTitlePolymorphisms of tumour necrosis factors A and B in breast cancer Eur J Immunogenet 29 7–10 Occurrence Handle11841482 Occurrence Handle1:CAS:528:DC%2BD38Xit1Wltb8%3D Occurrence Handle10.1046/j.0960-7420.2001.00260.x

    Article  PubMed  CAS  Google Scholar 

  24. EM El-Omar M Carrington WH Chow et al. (2000) ArticleTitleInterleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 398–402 Occurrence Handle10746728 Occurrence Handle1:CAS:528:DC%2BD3cXitlyltb4%3D Occurrence Handle10.1038/35006081

    Article  PubMed  CAS  Google Scholar 

  25. J Eskdale D Kube H Tesch G Gallagher (1997) ArticleTitleMapping of the human IL-10 gene and further characterisation of the 5′ flanking sequence Immunogenetics 46 120–8 Occurrence Handle9162098 Occurrence Handle1:CAS:528:DyaK2sXkslaiur8%3D Occurrence Handle10.1007/s002510050250

    Article  PubMed  CAS  Google Scholar 

  26. Howell WM. Interleukin-10 gene polymorphisms and cancer. In Marincola FM, (ed): Interleukin-10. Eurekah.com; pp. 1–17

  27. DM Turner DM Williams D Sankaran M Lazarus PJ Sinnott IV Hutchinson (1997) ArticleTitleAn investigation of polymorphism in the Interleukin-10 gene promoter Eur J Immunogenetics 24 1–8 Occurrence Handle1:CAS:528:DyaK2sXhsFCjsL0%3D

    CAS  Google Scholar 

  28. E Crawley R Kay J Sillibourne P Patel I Hutchinson P Woo (1999) ArticleTitlepolymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis Rheum 42 1101–8 Occurrence Handle10366102 Occurrence Handle1:CAS:528:DyaK1MXktVegt70%3D Occurrence Handle10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y

    Article  PubMed  CAS  Google Scholar 

  29. SC Hoffman EM Stanley ED Cox et al. (2001) ArticleTitleAssociation of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes Transplantation 72 1444–50 Occurrence Handle10.1097/00007890-200110270-00019

    Article  Google Scholar 

  30. E Reuss R Fimmers A Kruger C Becker C Rittner T Hohler (2002) ArticleTitleDifferential regulation of Interleukin-10 production by genetic and environmental factors: a twin study Genes Immun 3 407–13 Occurrence Handle12424622 Occurrence Handle1:CAS:528:DC%2BD38XosFamurw%3D Occurrence Handle10.1038/sj.gene.6363920

    Article  PubMed  CAS  Google Scholar 

  31. J Eskdale G Gallagher CL Verweij V Keijsers RG Westendorp TW Huizinga (1998) ArticleTitleInterleukin 10 secretion in relation to human IL-10 locus haplotypes Proc Natl Acad Sci USA 95 9465–70 Occurrence Handle9689103 Occurrence Handle1:CAS:528:DyaK1cXltlCls70%3D Occurrence Handle10.1073/pnas.95.16.9465

    Article  PubMed  CAS  Google Scholar 

  32. RG Westendorp JA Langermans TW Huizinga et al. (1997) ArticleTitleGenetic influence on cytokine production and fatal meningococcal disease Lancet 349 170–3 Occurrence Handle9111542 Occurrence Handle1:STN:280:ByiB28rmtlI%3D Occurrence Handle10.1016/S0140-6736(96)06413-6

    Article  PubMed  CAS  Google Scholar 

  33. WM Howell SJ Turner AC Bateman et al. (2001) ArticleTitleIL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma Genes and Immun 2 25–31 Occurrence Handle1:CAS:528:DC%2BD3MXitV2ksL4%3D Occurrence Handle10.1038/sj.gene.6363726

    Article  CAS  Google Scholar 

  34. JA Martinez-Escribano MR Moya-Quiles M Muro et al. (2002) ArticleTitleInterleukin-10, Interleukin-6 and interferon-γ gene polymorphisms in melanoma patients Melanoma Res 12 465–9 Occurrence Handle12394188 Occurrence Handle1:CAS:528:DC%2BD38XotVOisrk%3D Occurrence Handle10.1097/00008390-200209000-00008

    Article  PubMed  CAS  Google Scholar 

  35. SL McCarron S Edwards PR Evans et al. (2002) ArticleTitleInfluence of cytokine gene polymorphisms on the development of prostate cancer Cancer Res 62 3369–72 Occurrence Handle12067976 Occurrence Handle1:CAS:528:DC%2BD38XkslWqsLs%3D

    PubMed  CAS  Google Scholar 

  36. KC Smith AC Bateman HM Fussell WM Howell (2004) ArticleTitleCytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur J Immunogenet 31 167–73 Occurrence Handle15265021 Occurrence Handle1:CAS:528:DC%2BD2cXnsFSjsr8%3D Occurrence Handle10.1111/j.1365-2370.2004.00462.x

    Article  PubMed  CAS  Google Scholar 

  37. L Giordani P Bruzzi M Quaranta et al. (2004) ArticleTitlePolymorphisms of Interleukin-10 and tumour necrosis factor-α gene promoter and breast cancer risk Clin Chem 49 1664–7 Occurrence Handle10.1373/49.10.1664

    Article  Google Scholar 

  38. U Langsenlehner P Krippl W Renner et al. (2005) ArticleTitleInterleukin-10 promoter polymorphism is associated with decreased breast cancer risk Breast Cancer Res Treat 90 113–5 Occurrence Handle15803357 Occurrence Handle1:CAS:528:DC%2BD2MXivVKhs74%3D Occurrence Handle10.1007/s10549-004-3607-7

    Article  PubMed  CAS  Google Scholar 

  39. EA Bulpitt C Baynes AM Dunning PR Evans DF Easton BAJ Ponder R Gibbs WM. Howell (2004) ArticleTitleInvestigation of Interleukin-10 and vascular endothelial growth factor single nucleotide polymorphisms in predisposition to breast cancer Genes Immun 5 IssueIDSuppl. 1 S53

    Google Scholar 

  40. GA Stanczuk EN Sibanda C Perrey et al. (2001) ArticleTitleCancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production Int J Cancer 94 792–4 Occurrence Handle11745479 Occurrence Handle1:CAS:528:DC%2BD3MXotFOkur0%3D Occurrence Handle10.1002/ijc.1543

    Article  PubMed  CAS  Google Scholar 

  41. JW Roh MH Kim SS Seo et al. (2002) ArticleTitleInterleukin-10 promoter polymorphisms and cervical cancer risk in Korean women Cancer Lett 184 57–63 Occurrence Handle12104048 Occurrence Handle1:CAS:528:DC%2BD38XkvFyktLo%3D Occurrence Handle10.1016/S0304-3835(02)00193-3

    Article  PubMed  CAS  Google Scholar 

  42. M-S Wu C-Y Wu C-J Chen et al. (2003) ArticleTitleInterleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese Int J Cancer 104 617–23 Occurrence Handle12594817 Occurrence Handle1:CAS:528:DC%2BD3sXisVehtLo%3D Occurrence Handle10.1002/ijc.10987

    Article  PubMed  CAS  Google Scholar 

  43. M-S Wu S-P Huang Y-T Chang et al. (2002) ArticleTitleTumour necrosis factor-α and Interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma J Infect Dis 185 106–9 Occurrence Handle11756988 Occurrence Handle1:CAS:528:DC%2BD38XmvFajuw%3D%3D Occurrence Handle10.1086/324771

    Article  PubMed  CAS  Google Scholar 

  44. EM El-Omar CS Rabkin MD Gammon et al. (2003) ArticleTitleIncreased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms Gastroenterology 124 1193–1201 Occurrence Handle12730860 Occurrence Handle1:CAS:528:DC%2BD3sXktVSktrw%3D Occurrence Handle10.1016/S0016-5085(03)00157-4

    Article  PubMed  CAS  Google Scholar 

  45. E Alamartine E Berthoux C Mariat et al. (2003) ArticleTitleInterleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation J Invest Dermatol 120 99–103 Occurrence Handle12535204 Occurrence Handle10.1046/j.1523-1747.2003.12016.x

    Article  PubMed  Google Scholar 

  46. HD Shin BL Park LH Kim et al. (2003) ArticleTitleInterleukin 10 haplotype associated with increased risk of hepatocellular carcinoma Hum Mol Genet 12 901–6 Occurrence Handle12668613 Occurrence Handle1:CAS:528:DC%2BD3sXjvVyktro%3D Occurrence Handle10.1093/hmg/ddg104

    Article  PubMed  CAS  Google Scholar 

  47. Havranek E, Howell WM, Fussell HM, Whelan JA, Whelan MA, Pandha HS. An IL-10 promoter polymorphism may influence tumour development in renal cell carinoma. J Urol 2005; 173: 709–12

    Google Scholar 

  48. C Zheng D Huang L Liu et al. (2001) ArticleTitleInterleukin-10 gene promoter polymorphisms in multiple myeloma Int J Cancer 95 184–8 Occurrence Handle11307152 Occurrence Handle1:CAS:528:DC%2BD3MXjvFOmtr8%3D Occurrence Handle10.1002/1097-0215(20010520)95:3<184::AID-IJC1031>3.0.CO;2-V

    Article  PubMed  CAS  Google Scholar 

  49. D Gowans A O’Sullivan S Rollison et al. (2002) ArticleTitleAllele and Haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology Br J Haematol 117 541–5 Occurrence Handle12028020 Occurrence Handle1:CAS:528:DC%2BD38Xlt1Cqs7o%3D Occurrence Handle10.1046/j.1365-2141.2002.03452.x

    Article  PubMed  CAS  Google Scholar 

  50. LM Cunningham C Chapman R Dunstan et al. (2003) ArticleTitlePolymorphisms in the Interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin’s lymphoma Leukemia Lymphoma 44 251–5 Occurrence Handle12688341 Occurrence Handle1:STN:280:DC%2BD3s7mvFyjtg%3D%3D Occurrence Handle10.1080/1042819021000035590

    Article  PubMed  CAS  Google Scholar 

  51. EC Breen WJ Boscardin R Detels et al. (2003) ArticleTitleNon-Hodgkin’s B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL-10, or the IL-10 promoter -592 C/C genotype Clin Immunol 109 119–29 Occurrence Handle14597210 Occurrence Handle1:CAS:528:DC%2BD3sXos1CjtL8%3D Occurrence Handle10.1016/S1521-6616(03)00214-6

    Article  PubMed  CAS  Google Scholar 

  52. E Lech-Maranda L Baseggio J Bienvenu et al. (2004) ArticleTitleInterleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma Blood 103 3529–34 Occurrence Handle14701701 Occurrence Handle1:CAS:528:DC%2BD2cXjslKgtLw%3D Occurrence Handle10.1182/blood-2003-06-1850

    Article  PubMed  CAS  Google Scholar 

  53. LR Munro PW Johnston NA Marshall et al. (2003) ArticleTitlePolymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma Leukemia & Lymphoma 44 2083–8 Occurrence Handle1:CAS:528:DC%2BD3sXosVGisbw%3D Occurrence Handle10.1080/1042819031000119316

    Article  CAS  Google Scholar 

  54. M Lauten T Matthias M Stanulla et al. (2002) ArticleTitleAssociation of initial response to prednisone treatment in childhood acute leukaemia and polymorphism within the tumour necrosis factor and the Interleukin-10 gene Leukemia 16 1437–42 Occurrence Handle12145682 Occurrence Handle1:CAS:528:DC%2BD38Xls1WqsLw%3D Occurrence Handle10.1038/sj.leu.2402545

    Article  PubMed  CAS  Google Scholar 

  55. A DeMichele AM Martin R Mick et al. (2003) ArticleTitleInterleukin-6 –174 G→C polymorphism is associated with high risk breast cancer Cancer Res 15 8051–6

    Google Scholar 

  56. LS Ito H Iwata N Hamajima et al. (2002) ArticleTitleSignificant reduction in breast cancer risk for Japanese women with interleukin1B – 31CT/TT relative to CC genotype Jpn J Clin Oncol 32 398–402 Occurrence Handle12451035 Occurrence Handle10.1093/jjco/hyf081

    Article  PubMed  Google Scholar 

  57. A Saha V Gupta NK Bairwa D Malhotra R Bamezai (2004) ArticleTitleTransforming growth factor-bta1 genotype in sporadic breast cancer patients from India: status of enhancer, promoter, 5′-untranslated-region and exon-1 polymorphisms Eur J Immunogenet 31 37–42 Occurrence Handle15009180 Occurrence Handle1:CAS:528:DC%2BD2cXjtlGjtLw%3D Occurrence Handle10.1111/j.1365-2370.2004.00442.x

    Article  PubMed  CAS  Google Scholar 

  58. KM Lee SK Park N Hamajima et al. (2005) ArticleTitleGenetic polymorphisms of TGF-beta 1 and TNF-beta and breast cancer risk Breast Cancer Res Treat 90 149–55 Occurrence Handle15803361 Occurrence Handle1:CAS:528:DC%2BD2MXivVKhs70%3D Occurrence Handle10.1007/s10549-004-3859-2

    Article  PubMed  CAS  Google Scholar 

  59. AM Dunning PD Ellis S McBride et al. (2003) ArticleTitleA transforming growth factor beta 1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer Cancer Res 63 2610–5 Occurrence Handle12750287 Occurrence Handle1:CAS:528:DC%2BD3sXjsleht7w%3D

    PubMed  CAS  Google Scholar 

  60. JH Barrett W Thomson W Ollier (2000) HLA and disease association: statistical considerations JL Bidwell C Navarrete (Eds) Histocompatibility Testing Imperial College Press London 439–452

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Martin Howell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Howell, W.M., Rose-Zerilli, M.J. Interleukin-10 Polymorphisms, Cancer Susceptibility and Prognosis. Familial Cancer 5, 143–149 (2006). https://doi.org/10.1007/s10689-005-0072-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-005-0072-3

Key words

Navigation